Cohen E P, Molteni A, Hill P, Fish B L, Ward W F, Moulder J E, Carone F A
Department of Medicine, Medical College of Wisconsin, Milwaukee, USA.
Lab Invest. 1996 Sep;75(3):349-60.
Captopril protects rat lung from radiation-induced pneumonitis and fibrosis and preserves function and survival in experimental radiation nephropathy. This study determined the structural benefit of captopril used preventively in radiation nephropathy. Twenty-eight Wag/RijMCW rats, divided in six groups, received 0 to 17 Gray total body irradiation followed by syngeneic bone marrow transplant. Captopril 0, 62.5, 125, 250, or 500 mg/l was given in the drinking water from the time of irradiation, and the rats were killed at 20 weeks. Using light and electron microscopy, kidneys of irradiated no-drug rats showed glomerular tuft capsular adhesions and hyalinization, focal tubular necrosis, severe interstitial fibrosis, and marked thickening and hyaline degeneration of the wall of interlobular arteries and arterioles, with intimal proliferation and periadventitial edema and inflammation. Lumens of the smaller arteries were often occluded. Significant collagen deposition was present in glomeruli, interstitium, and adventitia of interlobular arteries. Marked reduction of glomerular, tubular, vascular, and interstitial damage was seen in irradiated, captopril-treated animals, with only mild focal tubular interstitial injury and fibrosis seen. alpha smooth muscle actin-positive cells, probably myofibroblasts, were enhanced in the irradiated kidneys, and this expression was reduced in a dose-related fashion by captopril. There was also reduction in the arteriolar wall thickening, luminal occlusion, and collagen deposition in captopril-treated animals. The presence of elastin was not affected by radiation or drug treatment. Blood pressure and azotemia were lower and survival was higher in irradiated drug-treated rats compared with irradiated no-drug rats. We conclude that captopril exerts significant functional and structural protection against renal radiation injury. There was notable reduction in radiation-induced fibrosis in captopril-treated animals in this model, as in experimental lung radiation injury.
卡托普利可保护大鼠肺部免受辐射诱导的肺炎和纤维化影响,并在实验性放射性肾病中维持肾功能和提高生存率。本研究确定了预防性使用卡托普利在放射性肾病中的结构益处。将28只Wag/RijMCW大鼠分为六组,接受0至17格雷的全身照射,随后进行同基因骨髓移植。从照射时起,在饮用水中给予0、62.5、125、250或500毫克/升的卡托普利,20周后处死大鼠。使用光镜和电镜观察,未用药的照射大鼠肾脏显示肾小球毛细血管丛与肾小囊粘连及玻璃样变、局灶性肾小管坏死、严重的间质纤维化,以及小叶间动脉和小动脉壁明显增厚和玻璃样变性,伴有内膜增生、外膜周围水肿和炎症。较小动脉的管腔常被阻塞。肾小球、间质和小叶间动脉外膜有明显的胶原沉积。在接受卡托普利治疗的照射动物中,肾小球、肾小管、血管和间质损伤明显减轻,仅见轻度局灶性肾小管间质损伤和纤维化。α平滑肌肌动蛋白阳性细胞(可能是肌成纤维细胞)在照射后的肾脏中增多,而卡托普利以剂量相关的方式减少了这种表达。在接受卡托普利治疗的动物中,小动脉壁增厚、管腔阻塞和胶原沉积也减少。弹性蛋白的存在不受辐射或药物治疗的影响。与未用药的照射大鼠相比,接受药物治疗的照射大鼠血压和氮质血症较低,生存率较高。我们得出结论,卡托普利对肾脏辐射损伤具有显著的功能和结构保护作用。在该模型中,与实验性肺部辐射损伤一样,接受卡托普利治疗的动物辐射诱导的纤维化明显减少。